305 related articles for article (PubMed ID: 6609984)
1. HLA-DR antigens of autologous melanoma and B lymphoblastoid cell lines: differences in glycosylation but not protein structure.
Alexander S; Hubbard SC; Strominger JL
J Immunol; 1984 Jul; 133(1):315-20. PubMed ID: 6609984
[TBL] [Abstract][Full Text] [Related]
2. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the oligosaccharides on the HLA-DR and DC1 B cell antigens.
Shackelford DA; Strominger JL
J Immunol; 1983 Jan; 130(1):274-82. PubMed ID: 6600184
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the biosynthesis of HLA-DR glycoproteins in human malignant melanoma cell lines.
Lloyd KO; Ng J; Dippold WG
J Immunol; 1981 Jun; 126(6):2408-13. PubMed ID: 6785352
[TBL] [Abstract][Full Text] [Related]
5. HLA-DR antigens have polymorphic light chains and invariant heavy chains as assessed by lysine-containing tryptic peptide analysis.
Kaufman JF; Andersen RL; Strominger JL
J Exp Med; 1980 Aug; 152(2 Pt 2):37s-53s. PubMed ID: 6774044
[TBL] [Abstract][Full Text] [Related]
6. Differential Ia antigen expression by autologous human erythroid and B lymphoblastoid cell lines.
Symington FW; Levine F; Braun M; Brown SL; Erlich HA; Torok-Storb B
J Immunol; 1985 Aug; 135(2):1026-32. PubMed ID: 3874223
[TBL] [Abstract][Full Text] [Related]
7. Identification of the MT3 molecule from HLA-DR4, 7, and w9 homozygous cell lines.
Mukai R; Suzuki M; Yabe T; Hamaguchi H; Maeda H
J Immunol; 1984 Dec; 133(6):3211-9. PubMed ID: 6436378
[TBL] [Abstract][Full Text] [Related]
8. Discoordinate surface expression of IFN-gamma-induced HLA class II proteins in nonprofessional antigen-presenting cells with absence of DM and class II colocalization.
Muczynski KA; Anderson SK; Pious D
J Immunol; 1998 Apr; 160(7):3207-16. PubMed ID: 9531276
[TBL] [Abstract][Full Text] [Related]
9. Analysis of HLA-DR antigens by using monoclonal antibodies: recognition of conformational differences in biosynthetic intermediates.
Shackelford DA; Lampson LA; Strominger JL
J Immunol; 1981 Oct; 127(4):1403-10. PubMed ID: 6944380
[TBL] [Abstract][Full Text] [Related]
10. Structural relationships between the DR beta 1 and DR beta 2 subunits in DR4, 7, and w9 haplotypes and the DRw53 (MT3) specificity.
Matsuyama T; Schwenzer J; Silver J; Winchester R
J Immunol; 1986 Aug; 137(3):934-40. PubMed ID: 2424991
[TBL] [Abstract][Full Text] [Related]
11. Separation of three class II antigens from a homozygous human B cell line.
Shackelford DA; Lampson LA; Strominger JL
J Immunol; 1983 Jan; 130(1):289-96. PubMed ID: 6600185
[TBL] [Abstract][Full Text] [Related]
12. Demonstration of two distinct light chains in HLA-DR-associated antigens by two-dimensional gel electrophoresis.
de Kretser TA; Crumpton MJ; Bodmer JG; Bodmer WF
Eur J Immunol; 1982 Mar; 12(3):214-21. PubMed ID: 6178597
[TBL] [Abstract][Full Text] [Related]
13. Biosynthesis and glycosylation of the invariant chain associated with HLA-DR antigens.
Machamer CE; Cresswell P
J Immunol; 1982 Dec; 129(6):2564-9. PubMed ID: 6982931
[TBL] [Abstract][Full Text] [Related]
14. Analysis of surface mu-chain expression in human lymphoblastoid cell lines that do not produce light chains.
Hendershot L; Levitt D
J Immunol; 1984 Jan; 132(1):502-9. PubMed ID: 6418805
[TBL] [Abstract][Full Text] [Related]
15. HLA-DP can be expressed with or without -DR molecules on a malignant B cell line.
Pesando JM; Graf L; Hoffman P
J Immunol; 1986 Sep; 137(6):1932-6. PubMed ID: 3489045
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the N-linked glycopeptides of DQw1 and DR1 molecules.
Iturbe S; Narasimhan S; Merrick JM; Falk JA; Letarte M
J Immunol; 1986 Jun; 136(12):4588-95. PubMed ID: 3486905
[TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of the HLA-A2 antigen loss by melanoma cells SK-MEL-29.1.22 and SK-MEL-29.1.29.
Wang Z; Seliger B; Mike N; Momburg F; Knuth A; Ferrone S
Cancer Res; 1998 May; 58(10):2149-57. PubMed ID: 9605759
[TBL] [Abstract][Full Text] [Related]
18. Molecular identifications of HLA-DR4, MT3, and TB21 antigens on HLA-DR4 homozygous B cell lines.
Maeda H; Hirata R
J Immunol; 1984 Feb; 132(2):574-7. PubMed ID: 6418807
[TBL] [Abstract][Full Text] [Related]
19. The human HLA-DR antigens are encoded by multiple beta-chain loci.
Hurley CK; Nunez G; Winchester R; Finn OJ; Levy R; Capra JD
J Immunol; 1982 Nov; 129(5):2103-8. PubMed ID: 6811658
[TBL] [Abstract][Full Text] [Related]
20. [Primary structure of class II human histocompatibility antigens. 1st communication. Amino acid sequence of the N-terminal 198 residues of the beta chain of a HLA-Dw2,2;DR2,2-alloantigen (author's transl)].
Kratzin H; Yang CY; Götz H; Pauly E; Kölbel S; Egert G; Thinnes FP; Wernet P; Altevogt P; Hilschmann N
Hoppe Seylers Z Physiol Chem; 1981 Dec; 362(12):1665-9. PubMed ID: 6947956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
